MTND1P30

Across TCGA pan-cancer cohorts, MTND1P30 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MTND1P30 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MTND1P30 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P30 expression acts as an unfavorable survival marker, although some lineages such as UCS and DLBC show a favorable association.

SKCM, THYM, and ESCA are the cancer types where MTND1P30 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.058	0.757	<.001	66	view →
THYM	OS	Tertile	All	0.289	0.891	<.001	60	view →
ESCA	OS	Tertile	All	0.205	0.911	<.001	54	view →
PAAD	OS	Tertile	All	0.260	0.617	.005	36	view →
READ	OS	Tertile	II,III,IV	0.542	0.919	<.001	24	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
KIRC	DFS	Tertile	All	0.705	0.873	.004	18	view →
LUSC	OS	Tertile	II,III,IV	0.207	0.790	.001	18	view →
UCS	DFS	Tertile	III,IV	1.000	0.222	.046	12	view →
SARC	OS	Tertile	All	0.162	0.767	.002	9	view →
DLBC	DFS	Tertile	II,III,IV	1.000	0.395	.028	7	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MTND1P30–SKCM (DFS)

Open the SKCM breakdown →